IMMUNOMEDICS INC (CIK: 0000722830) EDGAR, Information, Filings... CompaniesBIO.Com

IMMUNOMEDICS INC

Mailing address
300 AMERICAN ROAD, MORRIS PLAINS, Delaware, 07950
Phone
9736058200
State location
New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

IMMUNOMEDICS INC (CIK: 0000722830) is an American company incorporated in the state of New Jersey. Head office is located at 300 AMERICAN RD, MORRIS PLAINS, New Jersey, 07950. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. IMMUNOMEDICS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Semerjian Harout	0001809747	Apr-16-2020	director, officer: President and CEO
Azelby Robert	0001656998	Feb-26-2020	director
ITRI LORETTTA M	0001137918	Feb-13-2020	officer: Chief Medical Officer
Delaney Brendan	0001722585	Mar-14-2019	officer: CHIEF COMMERCIAL OFFICER
Duncan Barbara Gayle	0001353128	Mar-05-2019	director
BALL BRYAN	0001766522	Mar-05-2019	officer: Chief Quality Officer
BAUM CHARLES M	0001579824	Feb-23-2019	director
Andrews Kurt J.	0001636133	Sep-24-2018	officer: CHIEF HUMAN RESOURCES OFFICER
Freedberg Jared	0001754157	Sep-24-2018	officer: GENERAL COUNSEL
Fricker William	0001752213	Aug-23-2018	officer: See Remarks
ROSENBERG MORRIS	0001202786	Apr-12-2018	officer: See Remarks
Iannone Robert	0001737329	Apr-12-2018	officer: See Remarks
Malik Usama	0001737803	Apr-12-2018	officer: See Remarks
PEHL MICHAEL F.	0001677939	Dec-07-2017	director, officer: President and CEO
Garone Michael	0001307553	Jul-03-2017	officer: Chief Financial Officer
HUTT PETER BARTON	0001171527	Mar-13-2017	director
Canute Scott A	0001303416	Mar-13-2017	director
venBio Select Advisor LLC	0001633313	Mar-13-2017	director
Aghazadeh Behzad	0001701815	Mar-13-2017	director
Islam Khalid	0001701858	Mar-13-2017	director
COX GEOFFREY F	0001021014	Jan-08-2017	director
Forrester Robert	0001319890	Jan-08-2017	director
Aryeh Jason	0001376960	Jan-08-2017	director
Oliver Bob	0001694534	Jan-08-2017	director
Sherman Richard L.	0001584616	Dec-01-2015	director
Kirsch Arthur S	0001290976	Aug-18-2015	director
GOLDENBERG DAVID M	0001029578	Jul-14-2015	director, officer: CSO & Chairman of the BOD
GOLDENBERG CYNTHIA L	0001202016	Jul-14-2015	director, officer: President and CEO
PFREUNDSCHUH PETER P.	0001585839	Mar-09-2015	officer: Chief Financial Officer
LoCastro Marcella	0001520136	Mar-06-2012	director
ZUERBLIS KENNETH J	0001007923	Feb-09-2010	director
Wolynic Edward T	0001326727	Aug-01-2007	director
PAETZOLD MARY E	0001247904	Jul-01-2007	director
Stark Don C	0001314282	Jan-10-2005	director
MARKISON BRIAN A	0001283061	Oct-07-2004	director
JAFFE MARVIN	0001190430	Jul-01-2004	director
PIVIROTTO RICHARD R	0001197171	Jul-01-2004	director
COLEMAN MORTON	0001247901	Jul-01-2004	director
HORAK IVAN D	0001247903	Jun-09-2004	officer: EVP R&D & Ch. Scientific Off.
GORMAN GERARD G	0001247902	Apr-02-2004	officer: VP of Finance & CFO
MULLANEY JOSEPH E III	0001258996	Oct-20-2003	officer: VP & General Counsel

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by IMMUNOMEDICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000899140-21-000306 (34 Act) Size: KB	Feb-16-2021	005-35857 21637146
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000834237-20-010496 (34 Act) Size: KB	Nov-09-2020	005-35857 201298167
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001104659-20-120270 (34 Act) Size: KB	Nov-02-2020	000-12104 201279052
EFFECT	Document	Acc-no: 9999999995-20-003038 (33 Act) Size: KB	Oct-29-2020	333-90338 201274585
EFFECT	Document	Acc-no: 9999999995-20-003019 (33 Act) Size: KB	Oct-29-2020	333-219594 201274562
EFFECT	Document	Acc-no: 9999999995-20-003017 (33 Act) Size: KB	Oct-29-2020	333-184377 201274560
EFFECT	Document	Acc-no: 9999999995-20-003015 (33 Act) Size: KB	Oct-29-2020	333-114810 201274565
EFFECT	Document	Acc-no: 9999999995-20-003018 (33 Act) Size: KB	Oct-29-2020	333-198766 201274564
EFFECT	Document	Acc-no: 9999999995-20-003016 (33 Act) Size: KB	Oct-29-2020	333-128310 201274559
EFFECT	Document	Acc-no: 9999999995-20-003020 (33 Act) Size: KB	Oct-29-2020	333-225550 201274558
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-20-118646 ( Act) Size: 0 KB	Oct-27-2020
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117876 (33 Act) Size: KB	Oct-26-2020	033-16260 201258774
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117872 (33 Act) Size: KB	Oct-26-2020	033-56844 201258772
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117815 (33 Act) Size: KB	Oct-26-2020	033-43595 201258655
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117812 (33 Act) Size: KB	Oct-26-2020	333-239273 201258641
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117811 (33 Act) Size: KB	Oct-26-2020	333-239272 201258640
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117810 (33 Act) Size: KB	Oct-26-2020	333-201470 201258638
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117809 (33 Act) Size: KB	Oct-26-2020	333-143420 201258633
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001104659-20-117808 (33 Act) Size: KB	Oct-26-2020	333-53224 201258631
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-20-117806 ( Act) Size: 0 KB	Oct-23-2020

Recent 20 filings. View all IMMUNOMEDICS INC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

IMMUNOMEDICS INC overview
IMMUNOMEDICS INC job
IMMUNOMEDICS INC stock
IMMUNOMEDICS INC ownership
IMMUNOMEDICS INC CEO
IMMUNOMEDICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.